Nacer Lounis

8.8k total citations · 3 hit papers
59 papers, 5.8k citations indexed

About

Nacer Lounis is a scholar working on Infectious Diseases, Epidemiology and Molecular Biology. According to data from OpenAlex, Nacer Lounis has authored 59 papers receiving a total of 5.8k indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Infectious Diseases, 35 papers in Epidemiology and 18 papers in Molecular Biology. Recurrent topics in Nacer Lounis's work include Tuberculosis Research and Epidemiology (45 papers), Mycobacterium research and diagnosis (29 papers) and Cancer therapeutics and mechanisms (17 papers). Nacer Lounis is often cited by papers focused on Tuberculosis Research and Epidemiology (45 papers), Mycobacterium research and diagnosis (29 papers) and Cancer therapeutics and mechanisms (17 papers). Nacer Lounis collaborates with scholars based in France, Belgium and United States. Nacer Lounis's co-authors include Koen Andries, C. Truffot-Pernot, Jérôme Guillemont, Anil Koul, Vincent Jarlier, Éric Arnoult, J Grosset, Jean‐Marc Neefs, Peter Williams and Peter Verhasselt and has published in prestigious journals such as Nature, Science and New England Journal of Medicine.

In The Last Decade

Nacer Lounis

57 papers receiving 5.6k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A Diarylquinoline Drug Active on the ATP Synthase of Mycobacterium tuberculosis

2004 1.6k citations Koen Andries, Peter Verhasselt et al. Science profile →
The challenge of new drug discovery for tuberculosis

2011 831 citations Nacer Lounis, Jérôme Guillemont et al. profile →
Multidrug-Resistant Tuberculosis and Culture Conversion with Bedaquiline

2014 505 citations Alexander S. Pym, I. А. Vаsilyevа et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Nacer Lounis France	31	4.4k	3.3k	2.3k	1.0k	757	59	5.8k
Anne J. Lenaerts United States	42	3.2k 0.7×	2.3k 0.7×	1.9k 0.8×	703 0.7×	830 1.1×	93	5.0k
C. Truffot-Pernot France	34	3.9k 0.9×	3.4k 1.0×	1.7k 0.7×	1.1k 1.0×	457 0.6×	96	5.1k
Sven Hoffner Sweden	39	5.1k 1.2×	4.3k 1.3×	1.8k 0.8×	1.8k 1.7×	576 0.8×	127	6.7k
Tanya Parish United States	50	5.0k 1.1×	3.8k 1.2×	4.0k 1.7×	603 0.6×	807 1.1×	195	7.8k
Michael H. Cynamon United States	41	2.9k 0.7×	2.5k 0.8×	1.5k 0.7×	553 0.5×	946 1.2×	132	4.8k
Eric L. Nuermberger United States	51	6.6k 1.5×	4.6k 1.4×	2.5k 1.1×	1.4k 1.4×	477 0.6×	169	8.1k
Ken Duncan United Kingdom	31	3.0k 0.7×	2.4k 0.7×	1.9k 0.8×	583 0.6×	683 0.9×	52	4.7k
James C. Sacchettini United States	38	3.4k 0.8×	2.4k 0.7×	3.4k 1.5×	509 0.5×	1.1k 1.4×	41	6.4k
Valerie Mizrahi South Africa	47	4.3k 1.0×	3.1k 0.9×	3.7k 1.6×	698 0.7×	435 0.6×	142	7.0k
Véronique Dartois United States	56	6.6k 1.5×	4.7k 1.4×	3.8k 1.7×	1.6k 1.6×	786 1.0×	202	10.2k

Countries citing papers authored by Nacer Lounis

Since Specialization

Citations

This map shows the geographic impact of Nacer Lounis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nacer Lounis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nacer Lounis more than expected).

Fields of papers citing papers by Nacer Lounis

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nacer Lounis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nacer Lounis. The network helps show where Nacer Lounis may publish in the future.

Co-authorship network of co-authors of Nacer Lounis

This figure shows the co-authorship network connecting the top 25 collaborators of Nacer Lounis. A scholar is included among the top collaborators of Nacer Lounis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nacer Lounis. Nacer Lounis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lounis, Nacer, et al.. (2024). Mice infected with M . tuberculosis with Rv0678 mutations still benefit from bedaquiline treatment. SHILAP Revista de lepidopterología. 1(11). 525–527.

Chauffour, Aurélie, Nacer Lounis, Koen Andries, et al.. (2023). Minimal effective dose of bedaquiline administered orally and activity of a long acting formulation of bedaquiline in the murine model of leprosy. PLoS neglected tropical diseases. 17(11). e0011379–e0011379. 5 indexed citations

Kaniga, Koné, et al.. (2022). Impact of Rv0678 mutations on patients with drug-resistant TB treated with bedaquiline. The International Journal of Tuberculosis and Lung Disease. 26(6). 571–573. 8 indexed citations

Chauffour, Aurélie, Vincent Jarlier, Nacer Lounis, et al.. (2020). Fully weekly antituberculosis regimen: a proof-of-concept study. European Respiratory Journal. 56(3). 1902502–1902502. 1 indexed citations

Martin, Anandi, et al.. (2019). In vitro activity of bedaquiline against slow-growing nontuberculous mycobacteria. Journal of Medical Microbiology. 68(8). 1137–1139. 20 indexed citations

Lounis, Nacer, Luc Vranckx, Tom Gevers, Koné Kaniga, & Koen Andries. (2016). In vitro culture conditions affecting minimal inhibitory concentration of bedaquiline against M. tuberculosis. Médecine et Maladies Infectieuses. 46(4). 220–225. 17 indexed citations

Kaniga, Koné, Daniela María Cirillo, Sven Hoffner, et al.. (2016). A Multilaboratory, Multicountry Study To Determine Bedaquiline MIC Quality Control Ranges for Phenotypic Drug Susceptibility Testing. Journal of Clinical Microbiology. 54(12). 2956–2962. 35 indexed citations

Pym, Alexander S., Andreas H. Diacon, Shenjie Tang, et al.. (2015). Bedaquiline in the treatment of multidrug- and extensively drug-resistant tuberculosis. European Respiratory Journal. 47(2). 564–574. 226 indexed citations

Véziris, Nicolas, Nacer Lounis, Aurélie Chauffour, et al.. (2008). A Once-Weekly R207910-containing Regimen Exceeds Activity of the Standard Daily Regimen in Murine Tuberculosis. American Journal of Respiratory and Critical Care Medicine. 179(1). 75–79. 51 indexed citations

10.

Lounis, Nacer, et al.. (2008). Impact of the Interaction of R207910 with Rifampin on the Treatment of Tuberculosis Studied in the Mouse Model. Antimicrobial Agents and Chemotherapy. 52(10). 3568–3572. 50 indexed citations

11.

Andries, Koen, Nacer Lounis, Aurélie Chauffour, et al.. (2006). Synergistic Activity of R207910 Combined with Pyrazinamide against Murine Tuberculosis. Antimicrobial Agents and Chemotherapy. 51(3). 1011–1015. 130 indexed citations

12.

Tyagi, Sandeep, Eric L. Nuermberger, Tetsuyuki Yoshimatsu, et al.. (2005). Bactericidal Activity of the Nitroimidazopyran PA-824 in a Murine Model of Tuberculosis. Antimicrobial Agents and Chemotherapy. 49(6). 2289–2293. 174 indexed citations

13.

Andries, Koen, Peter Verhasselt, Jérôme Guillemont, et al.. (2004). A Diarylquinoline Drug Active on the ATP Synthase of Mycobacterium tuberculosis. Science. 307(5707). 223–227. 1632 indexed citations breakdown →

14.

Boelaert, Johan R., Rui Appelberg, Maria Salomé Gomes, et al.. (2001). Experimental Results on Chloroquine and AIDS-Related Opportunistic Infections. JAIDS Journal of Acquired Immune Deficiency Syndromes. 26(3). 300–301. 13 indexed citations

15.

Lounis, Nacer, C. Truffot-Pernot, J Grosset, Victor R. Gordeuk, & Johan R. Boelaert. (2001). Iron and Mycobacterium tuberculosis infection. Journal of Clinical Virology. 20(3). 123–126. 108 indexed citations

16.

Daniel, Nathalie, Nacer Lounis, Baohong Ji, et al.. (2000). Antituberculosis Activity of Once-weekly Rifapentine-containing Regimens in Mice: Long-term Effectiveness with 6- and 8-Month Treatment Regimens. American Journal of Respiratory and Critical Care Medicine. 161(5). 1572–1577. 26 indexed citations

17.

Lounis, Nacer, et al.. (1999). Impacts of interleukin-12 on multiplication of Mycobacterium tuberculosis and Mycobacterium avium complex in mice. Clinical Microbiology and Infection. 5(6). 331–338. 2 indexed citations

18.

Lounis, Nacer, Caroline Maslo, Johan R. Boelaert, et al.. (1999). Impact of iron loading and iron chelation on murine tuberculosis. Clinical Microbiology and Infection. 5(11). 687–692. 6 indexed citations

19.

Grosset, J, Nacer Lounis, C. Truffot-Pernot, et al.. (1998). Once-weekly Rifapentine-containing Regimens for Treatment of Tuberculosis in Mice. American Journal of Respiratory and Critical Care Medicine. 157(5). 1436–1440. 25 indexed citations

20.

Lounis, Nacer, Botao Ji, C. Truffot-Pernot, & J. Grosset. (1997). Which aminoglycoside or fluoroquinolone is more active against Mycobacterium tuberculosis in mice?. Antimicrobial Agents and Chemotherapy. 41(3). 607–610. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact